doxazosin has been researched along with Fatigue in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxazosin was usually added as the fifth antihypertensive drug in individuals who were either unresponsive to or intolerant of the combination of other antihypertensives." | 5.35 | Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. ( Ceral, J; Solar, M, 2009) |
| "Doxazosin was usually added as the fifth antihypertensive drug in individuals who were either unresponsive to or intolerant of the combination of other antihypertensives." | 1.35 | Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. ( Ceral, J; Solar, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akın, F | 1 |
| Kılıçaslan, C | 1 |
| Solak, ES | 1 |
| Uzun, M | 1 |
| Aygün, S | 1 |
| Arslan, Ş | 1 |
| Ceral, J | 1 |
| Solar, M | 1 |
2 other studies available for doxazosin and Fatigue
| Article | Year |
|---|---|
Posterior reversible encephalopathy syndrome in children: report of three cases.
Topics: Adolescent; Anticonvulsants; Antihypertensive Agents; Brain Stem; Cerebral Cortex; Child; Child, Pre | 2014 |
Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Diuretics; Dose-Response Relationship, | 2009 |